Prostate Cancer Clinical Trial
Official title:
Prostate Cancer Survivors MOving Toward Exercise (PROMOTE) Trial
The primary purpose of the study is to determine the effects of an implementation intention
intervention on physical activity (PA) behaviour in prostate cancer survivors. Secondary aims
are to (a) compare the effects of a telephone-assisted implementation intention intervention
against a self-administered implementation intention intervention and a standard
recommendation group on physical activity behaviour and (b) document the effects of these
interventions on quality of life (QoL), fatigue, symptom management, and physical
functioning.
Hypotheses: Evidence exists that an implementation intention intervention can lead to
significant improvements in PA levels and that regular PA has been shown to improve QoL,
fatigue levels, manage symptoms and improve physical functioning in cancer survivors'. As
such, the following hypotheses were generated: (1) prostate cancer survivors exposed to the
researcher-assisted implementation intention intervention will have higher PA levels at the
1- and 3-month follow-ups compared to the self-completed implementation intention
intervention and the standard recommendation group; (2) prostate cancer survivors in the
researcher-assisted implementation intention intervention will show significant improvements
in QoL, fatigue levels, symptom management, and physical functioning compared to the
self-completed implementation intention intervention and the standard recommendation group at
the 1- and 3-month follow-up; and (3) prostate cancer survivors in the self-completed
implementation intention intervention will have higher PA levels, and better improvements in
QoL, fatigue levels, symptom management, and physical functioning compared to the standard
recommendation group at the 1- and 3-month follow-ups.
BACKGROUND:
Prostate cancer remains the most frequently diagnosed cancer among Canadian men, with an
estimated 24,600 men being diagnosed in 2010. In Alberta specifically, roughly 2,500 men will
be diagnosed with prostate cancer, and 440 men will die of the disease in 2010 (Canadian
Cancer Society, 2011). Improvements in the treatment of prostate cancer has reduced tumour
growth and improved survival rates, however, it has also been associated with significant
negative changes in cancer survivors' quality of life, physical functioning, body fat
percentage and fatigue levels that may persist for years following treatment. One behavioural
strategy that has been consistently shown to combat these negative side effects and enhance
psychosocial and physical well-being in prostate cancer survivors is physical activity.
Unfortunately it has been established that physical activity levels decline significantly
from pre-diagnosis to during treatment and may never regain pre-diagnosis levels; thus it is
important to test novel, innovative and inexpensive ways to increase physical activity
patterns in prostate cancer survivors.
PURPOSE:
The primary purpose of the study is to determine the effects of an implementation intention
intervention on physical activity behaviour in prostate cancer survivors. Secondary aims are
to (a) compare the effects of a telephone-assisted implementation intention intervention
against a self-administered implementation intention intervention and a standard
recommendation group on physical activity behaviour and (b) document the effects of these
interventions on quality of life, fatigue, symptom management, and physical functioning.
METHODS:
A three-arm randomized controlled trial for prostate cancer survivors will be performed
through the Alberta Cancer Registry. To obtain a sample of at least 300 participants, 1500
prostate cancer survivors will be contacted in the initial mail-out. Following the initial
mail-out prostate cancer survivors agreeing to participate in the study will be randomized to
one of the three conditions. All groups will receive a written physical activity
recommendation, as well as the 2008 Physical Activity Guidelines. In addition to the physical
activity materials, participants in the telephone-assisted and self-administered groups will
be asked to complete an implementation intention intervention. Finally, the
telephone-assisted group will receive a 10-20 minute telephone call to assist them with the
completion of implementation intention intervention. Measures at baseline (i.e., initial
mail-out) will include self-reported physical activity, demographic, health and medical
factors, quality of life, fatigue, physical functioning. Follow-up at month 1 and 3 following
the intervention will include self-reported physical activity, quality of life, fatigue and
physical function measures.
SUMMARY:
This mail-out study will offer insight into the effects of an implementation intention
intervention on physical activity levels in an understudied cancer population, and further
explore the effect of physical activity as part of the usual care recommended for the
treatment of prostate cancer on quality of life, fatigue and symptom management.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05613023 -
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
|
Phase 3 | |
| Recruiting |
NCT05540392 -
An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05156424 -
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer
|
Phase 1/Phase 2 | |
| Completed |
NCT03177759 -
Living With Prostate Cancer (LPC)
|
||
| Completed |
NCT01331083 -
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer
|
Phase 2 | |
| Recruiting |
NCT05540782 -
A Study of Cognitive Health in Survivors of Prostate Cancer
|
||
| Active, not recruiting |
NCT04742361 -
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
|
Phase 3 | |
| Completed |
NCT04400656 -
PROState Pathway Embedded Comparative Trial
|
||
| Completed |
NCT02282644 -
Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry
|
N/A | |
| Recruiting |
NCT06305832 -
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
|
Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT05761093 -
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
|
||
| Completed |
NCT04838626 -
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
|
Phase 2/Phase 3 | |
| Recruiting |
NCT03101176 -
Multiparametric Ultrasound Imaging in Prostate Cancer
|
N/A | |
| Completed |
NCT03290417 -
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
|
N/A | |
| Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
| Completed |
NCT01497925 -
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer
|
Phase 1 | |
| Recruiting |
NCT03679819 -
Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
|
||
| Completed |
NCT03554317 -
COMbination of Bipolar Androgen Therapy and Nivolumab
|
Phase 2 | |
| Completed |
NCT03271502 -
Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy
|
N/A |